RxDoctor Payments Data

Harrinarine Madhosingh, MD

Infectious Disease · Celebration, FLNPI 1235214388

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $76,568 of the $77,188 with a category attached, or 99.2%. Axogen accounts for 99.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $25,347 and has fallen 99.9% since, to $27 in 2025. Among infectious disease clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$77,188in general payments, 2019–2025

Across 33 payments — averaging $2339.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$77K
  • Insmed, Inc.$171
  • AbbVie$144
  • Gilead$67
  • Merck$50
  • Johnson & Johnson$43
  • plus $32 from 2 others

What the payments were for

  • Consulting fees$76,56899%
  • Food & beverage$5681%
  • Education$520%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Axogen17$76,681
Insmed, Inc.5$171
AbbVie(2 entities)2$144
Gilead3$67
Merck2$50
Johnson & Johnson2$43
Med-el Corporation1$27
Kerecis Limited1$5

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$77,188 in reported general payments places this provider in the 95th percentile of 669 infectious disease providers in Florida.

See all infectious disease providers in Florida

Medicare billing

Part B allowed, 2024
$497,951
Medicare patients
578
Services billed
6,578

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Daptomycin180$318,469
TriumeqAbacavir/Dolutegravir/Lamivudi12$44,071
ErtapenemErtapenem Sodium73$32,903
Cefepime Hcl143$32,437
TivicayDolutegravir Sodium11$21,961
EvotazAtazanavir Sulfate/Cobicistat11$15,619
Meropenem57$10,902
Piperacillin-TazobactamPiperacillin Sodium/Tazobactam28$5,683
CeftriaxoneCeftriaxone Sodium46$4,102
Cefdinir176$2,107
Doxycycline Hyclate233$1,572
Levofloxacin182$1,560
Cefazolin Sodium21$795
Sodium Chloride0.9 % Sodium Chloride18$744
Minocycline Hcl14$613

Paid to pharmacies, not to this prescriber.

Other infectious disease in Celebration

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →